<menu id="wymuy"><strong id="wymuy"></strong></menu>
  • <menu id="wymuy"><strong id="wymuy"></strong></menu> <menu id="wymuy"></menu>
  • <menu id="wymuy"></menu>
  • <input id="wymuy"></input>
  • Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
    Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
    A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.
    Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
    Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases

    A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.

    A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.

    pharma & biotech
    NYU Langone to Drop Sackler Name from Biomedical Institute
    NYU Langone to Drop Sackler Name from Biomedical Institute
    Max Kozlov | Oct 26, 2020
    The decision comes after Purdue Pharma, founded by the Sackler family, announced it would plead guilty to federal criminal charges for its role in the opioid epidemic.
    Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
    Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
    Anthony King | Sep 8, 2020
    Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
    Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
    Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
    Catherine Offord | Sep 3, 2020
    A meta-analysis of seven randomized controlled trials concludes that dexamethasone and other corticosteroids reduce 28-day mortality in seriously ill patients.
    Last Chance to Enter Our Annual Top 10 Innovations Contest
    Last Chance to Enter Our Annual Top 10 Innovations Contest
    The Scientist Staff | Aug 18, 2020
    The deadline is this Friday to submit your new product and have a chance at being selected for a coveted spot in The Scientist’s 2020 competition.
    Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
    Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
    Catherine Offord | Aug 11, 2020
    Citizen advocates push the pharmaceutical company to examine a compound that has been used to treat certain coronavirus infections in cats.
    Thwarting a Pandemic: COVID-19 Vaccine Strategies
    Thwarting a Pandemic: COVID-19 Vaccine Strategies
    The Scientist Creative Services Team | Aug 6, 2020
    Download this poster to learn about promising vaccine candidates for COVID-19!
    Starting a New Lab
    Starting a New Lab
    The Scientist Creative Services Team | Aug 6, 2020
    Advice for new principal investigators starting their first research laboratories!
    Activities Discovered for Some Inactive Drug Ingredients
    Activities Discovered for Some Inactive Drug Ingredients
    Ruth Williams | Jul 23, 2020
    Screens of hundreds of drug excipients reveal that some can interact with biological targets, contradicting their FDA categorization as inert.
    How the Pharma Industry Pulled Off the Pivot to COVID-19
    How the Pharma Industry Pulled Off the Pivot to COVID-19
    Diana Kwon | Jul 13, 2020
    The urgent need for tests and therapeutics has brought companies together and pushed researchers to work at breakneck speeds.
    精选二四六天天好彩j